H.R. 826

H.R. 826: COVID Fraud Transparency Act of 2025

Reported by Committee Roger Williams (R) HOUSE_BILL — 119th Congress
Plain English Summary

The COVID Fraud Transparency Act of 2025 mandates that the Small Business Administration's Office of Inspector General provide quarterly reports on fraud cases related to specific COVID-19 loans, such as those from the Paycheck Protection Program.

Positive Media Summary

Supporters of the COVID Fraud Transparency Act of 2025 praise it for increasing accountability and transparency in the distribution of COVID-19 relief funds. They argue that regular reporting will help identify and address fraud, ensuring that aid reaches those who genuinely need it.

Negative Media Summary

Critics of the COVID Fraud Transparency Act of 2025 express concerns that the bill may create additional bureaucratic hurdles for small businesses seeking assistance. Some argue that the focus on fraud reporting could divert resources away from supporting businesses recovering from the pandemic.

Conflict of Interest Analysis Deep Analysis
2/10
Risk Level
Low
Total Donations
$787,500,000
PAC Percentage
0%
Policy Area
Commerce

The COVID Fraud Transparency Act of 2025, sponsored by Roger Williams, does not show any direct industry overlaps with the sponsor's top donor industries, which include Health Professionals and Retired individuals. While the Health Professionals sector has contributed a significant amount of $600 million, it does not directly relate to the bill's focus on COVID fraud transparency. The lack of PAC contributions further indicates that the funding is primarily from individual donors, which may dilute the influence of any single donor. Additionally, the lobbying activity in this policy area is largely undisclosed, making it difficult to ascertain specific conflicts of interest. However, the absence of direct financial ties to the bill's subject matter suggests a low risk of conflict for voters to be concerned about.

Lobbying Activity — Who's Pushing?

Organizations that lobbied on issues related to this bill's policy area.

Client Lobbying Firm Amount
DIRSHU INTERNATIONAL MERKAVA STRATEGIES CORPORATION $100,000
CEO WORKS SAUNDERS GLOBAL DIPLOMACY $45,000
KAZI IG SAUNDERS GLOBAL DIPLOMACY $15,000
SOUTHERN FOLGER CONTRACTING BBT STRATEGIES LLC $10,000
WATERFRONT GLOBAL BBT STRATEGIES LLC $5,200
DIGITALEUROPE VIVID STRATEGIES LLC undisclosed
INTERNATIONAL CHRISTIAN CHAMBER OF COMMERCE MERKAVA STRATEGIES CORPORATION undisclosed
DR. STEPHEN SOLOWAY MERKAVA STRATEGIES CORPORATION undisclosed
ONE ISRAEL FUND MERKAVA STRATEGIES CORPORATION undisclosed
HEMOGLOBIN OXYGEN THERAPEUTICS MERKAVA STRATEGIES CORPORATION undisclosed
ATAOLLAH AMINPOUR MERKAVA STRATEGIES CORPORATION undisclosed
HERSEL NEMAN MERKAVA STRATEGIES CORPORATION undisclosed
MORAD BEN NEMAN MERKAVA STRATEGIES CORPORATION undisclosed
MARK SCOTT MERKAVA STRATEGIES CORPORATION undisclosed
BORIS MINTS MERKAVA STRATEGIES CORPORATION undisclosed

Source: Senate Lobbying Disclosure Act (LDA) filings, 2026

Sponsor's Top Donor Industries

Top industries funding Roger Williams, ranked by total contributions.

Health Professionals $600,000,000
Individuals: $600,000,000 PACs: $0
Retired $187,500,000
Individuals: $187,500,000 PACs: $0

Source: OpenSecrets.org (Center for Responsive Politics)

TheBillRoom is free and independent. No ads, no subscriptions, no political funding. If this analysis was useful, reader support keeps it running.
Support Us